Proteomic analysis of homocysteine induced proliferation of cultured neonatal rat vascular smooth muscle cells

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 2, 2009, Pages 177-184

  Liu, XiaoHua ^a   Shen, Jing ^a   Zhan, Rui ^a   Wang, XingXing ^a   Wang, XiaoMing ^a   Zhang, ZhiQing ^a   Leng, Xue ^a   Yang, ZhiHua ^a   Qian, LingJia ^a  

^a INSTITUTE OF HEALTH AND ENVIRONMENTAL MEDICINE   (China)

Author keywords

Homocysteine; Proliferation; Two dimensional gel electrophoresis; Vascular smooth muscle cell

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALDEHYDE REDUCTASE; CALRETICULIN; HOMOCYSTEINE; LAMIN C; LIM PROTEIN; PROTEIN SH3; PYRUVATE KINASE; PYRUVATE KINASE M2; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GLYCOLYSIS; IMMUNOBLOTTING; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RAT; SMOOTH MUSCLE FIBER; TWO DIMENSIONAL GEL ELECTROPHORESIS; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; AORTA, THORACIC; CELL PROLIFERATION; CELLS, CULTURED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HOMOCYSTEINE; MYOCYTES, SMOOTH MUSCLE; PROTEOME; RATS; RATS, WISTAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

RATTUS;

EID: 58149250061     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2008.10.001     Document Type: Article

References (60)

1. Selhub J., Jacques P.F., Bostom A.G., D R.B., Agostino, Wilson P.W., Belanger A.J., O'Leary D.H., Wolf P.A., Schaefer E.J., and Rosenberg I.H. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N. Engl. J. Med. 332 5 (1995) 286-291
2. Huang T., Yuan G., Zhang Z., Zou Z., and Li D. Cardiovascular pathogenesis in hyperhomocysteinemia. Asia Pac. J. Clin. Nutr. 17 1 (2008) 8-16
3. Guo H., Lee J.D., Yue H., Uzui H., Xing Y., Wang J., Toyoda K., Geshi T., and Ueda T. Effect of erythromycin on homocysteine-induced extracellular matrix metalloproteinase-2 production in cultured rat vascular smooth muscle cells. Indian J. Med. Res. 121 6 (2005) 764-770
4. Duell P.B., and Malinow M.R. Homocysteine: an important risk factor for atherosclerotic vascular disease. Curr. Opin. Lipidol. 8 1 (1997) 28-34
5. Rodrigo R., Passalacqua W., Araya J., Orellana M., and Rivera G. Homocysteine and essential hypertension. J. Clin. Pharmacol. 43 12 (2003) 1299-1306
6. Schwartz S.M., deBlois D., O E.R.M., and Brien. The intima: soil for atherosclerosis and restenosis. Circ. Res. 77 3 (1995) 445-465
7. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med. Indones. 39 2 (2007) 86-93
8. Tsai J.C., Perrella M.A., Yoshizumi M., Hsieh C.M., Haber E., Schlegel R., and Lee M.E. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc. Natl. Acad. Sci. USA, 91 14 (1994) 6369-6373
9. Chen C., Halkos M.E., Surowiec S.M., Conklin B.S., Peter H.L., and Lumsden A.B. Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models. J. Surg. Res. 88 1 (2000) 26-33
10. Desai A., Lankford H.A., and Warren J.S. Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis. Inflammation 25 3 (2001) 179-186
11. Nishimoto S., Tawara J., Toyoda H., Kitamura K., and Komurasaki T. A novel homocysteine-responsive gene, smap8, modulates mitogenesis in rat vascular smooth muscle cells. Eur. J. Biochem. 270 11 (2003) 2521-2531
12. Wang G., Siow Y.L., and O K. Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem. J. 352 pt. 3 (2000) 817-826
13. Ozeki M., Hamajima Y., Feng L., Ondrey F.G., Schlentz E., and Lin J. Id1 induces the proliferation of cochlear sensory epithelial cells via the nuclear factor-kappaB/cyclin D1 pathway in vitro. J. Neurosci. Res. 85 3 (2007) 515-524
14. Dalton M.L., Jr Gadson P.F., Wrenn R.W., and Rosenquist T.H. Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells. FASEB J. 11 8 (1997) 703-711
15. Woo D.K., Dudrick S.J., and Sumpio B.E. Homocysteine stimulates MAP kinase in bovine aortic smooth muscle cells. Surgery 128 1 (2000) 59-66
16. Ozer Kartal N., Taha S., and Azzi A. Homocysteine induces DNA synthesis and proliferation of vascular smooth muscle cells by interfering with MAPK kinase pathway. Biofactors 24 1-4 (2005) 193-199
17. Liu X., Luo F., Li J., Wu W., Li L., and Chen H. Homocysteine induces connective tissue growth factor expression in vascular smooth muscle cells. J. Thromb. Haemost. 6 1 (2008) 184-192
18. Majors A., Ehrhart L.A., and Pezacka E.H. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17 10 (1997) 2074-2081
19. Raposo B., Rodríguez C., Martínez-González J., and Badimon L. High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells. Atherosclerosis 177 1 (2004) 1-8
20. Tsai J.C., Wang H., Perrella M.A., Yoshizumi M., Sibinga N.E., Tan L.C., Haber E., Chang T.H., Schlegel R., and Lee M.E. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J. Clin. Invest. 97 1 (1996) 146-153
21. Qureshi I., Chen H., Brown A.T., Fitzgerald R., Zhang X., Breckenridge J., Kazi R., Crocker A.J., Stühlinger M.C., Lin K., Cooke J.P., Eidt J.F., and Moursi M.M. Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor. Vasc. Med. 10 3 (2005) 215-223
22. Jiang X., Yang F., Brailoiu E., Jakubowski H., Dun N.J., Schafer A.I., Yang X., Durante W., and Wang H. Differential regulation of homocysteine transport in vascular endothelial and smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 27 9 (2007) 1976-1983
23. Ross R. The smooth muscle cell: II Growth of smooth muscle in culture and formation of elastic fibers. J. Cell. Biol. 50 1 (1971) 172-186
24. Witzmann F.A., Clack J.W., Geiss K., Hussain S., Juhl M.J., Rice C.M., and Wang C. Proteomic evaluation of cell preparation methods in primary hepatocyte cell culture. Electrophoresis 23 14 (2002) 2223-2232
25. Liu X.H., Qian L.J., Gong J.B., Shen J., Zhang X.M., and Qian X.H. Proteomic analysis of mitochondrial proteins in cardiomyocytes from chronic stressed rat. Proteomics 4 10 (2004) 3167-3176
26. Jungblut P., and Thiede B. Protein identification from 2-DE gels by MALDI mass spectrometry. Mass Spectrom. Rev. 16 3 (1997) 145-162
27. Dan Q., Wong R., Chung S.K., Chung S.S.M., and Lam K.S.L. Interaction between the polyol pathway and non-enzymatic glycation on aortic smooth muscle cell migration and monocyte adhesion. Life Sci. 76 4 (2004) 445-459
28. Leong S.F., Lai J.C., Lim L., and Clark J.B. Energy-metabolizing enzymes in brain regions of adult and aging rats. J. Neurochem. 37 6 (1981) 1548-1556
29. McGregor E., Kempster L., Wait R., Welson S.Y., Gosling M., Dunn M.J., and Powel J.T. Identification and mapping of human saphenous vein medial smooth muscle proteins by two-dimensional polyacrylamide gel electrophoresis. Proteomics 1 11 (2001) 1405-1414
30. Mayr U., Mayr M., Yin X., Begum S., Tarelli E., Wait R., and Xu Q. Proteomic dataset of mouse aortic smooth muscle cells. Proteomics 5 17 (2005) 4546-4557
31. Dupont A., Corseaux D., Dekeyzer O., Drobecq H., Guihot A.L., Susen S., Vincentelli A., Amouyel P., Jude B., and Pinet F. The proteome and secretome of human arterial smooth muscle cells. Proteomics 5 2 (2005) 585-596
32. McGregor E., Kempster L., Wait R., Gosling M., Dunn M.J., and Powell J.T. F-actin capping (CapZ) and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress: a proteonomic approach. Mol. Cell. Proteomics 3 2 (2004) 115-124
33. Lee C.K., Park H.J., So H.H., Kim H.J., Lee K.S., Choi W.S., Lee H.M., Won K.J., Yoon T.J., Park T.K., and Kim B. Proteomic profiling and identification of cofilin responding to oxidative stress in vascular smooth muscle. Proteomics 6 24 (2006) 6455-6475 Dec
34. Pshezhetsky A.V. Proteomic analysis of vascular smooth muscle cells treated with ouabain. Methods Mol. Biol. 357 (2007) 253-269
35. Wang Z., Wu W., Fang X., Wang Y., Xiao C., Zhao R., Wang L., and Qiao Z. Protein expression changed by nicotine in rat vascular smooth muscle cells. J. Physiol. Biochem. 63 2 (2007) 161-169
36. Patton W.F., Erdjument-Bromage H., Marks A.R., Tempst P., and Taubman M.B. Components of the protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents. Identification by comparative protein phenotyping and microsequencing. J. Biol. Chem. 270 36 (1995) 21404-21410
37. Boccardi C., Cecchettini A., Caselli A., Camici G., Evangelista M., Mercatanti A., Rainaldi G., and Citti L. A proteomic approach to the investigation of early events involved in vascular smooth muscle cell activation. Cell Tissue Res. 328 1 (2007) 185-195
38. Ma Z.C., Gao Y., Wang Y.G., Tan H.L., Xiao C.R., and Wang S.Q. Ginsenoside Rg1 inhibits proliferation of vascular smooth muscle cells stimulated by tumor necrosis factor-alpha. Acta Pharmacol. Sin. 27 8 (2006) 1000-1006
39. Meir K.S., and Leitersdorf E. Atherosclerosis in the apolipoprotein E-deficient mouse: a decade of progress. Arterioscler. Thromb. Vasc. Biol. 24 6 (2004) 1006-1014
40. Zhu B., Kuhel D.G., Witte D.P., and Hu D.Y. Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice. Am. J. Pathol. 157 6 (2000) 1839-1848
41. Mayr M., Zampetaki A., Sidibe A., Mayr U., Yin X., Souza De A.I., Chung Y.L., Madhu B., Quax P.H., Hu Y., Griffiths J.R., and Xu Q. Proteomic and metabolomic analysis of smooth muscle cells derived from the arterial media and adventitial progenitors of apolipoprotein E-deficient mice. Circ. Res. 102 9 (2008) 1046-1056
42. Steták A., Veress R., Ovádi J., Csermely P., Kéri G., and Ullrich A. Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death. Cancer Res. 67 4 (2007) 1602-1608
43. Jiang H., Wang X.F., Fang L., Tang C., Zhu Y., and Wang X. Upregulation of aldose reductase by homocysteine in type II alveolar epithelial cells. Biochem. Biophys. Res. Commun. 337 4 (2005) 1084-1091
44. Shaw S., Wang X., Redd H., Alexander G.D., Isales C.M., and Marrero M.B. High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. J. Biol. Chem. 278 33 (2003) 30634-30641
45. Xiao S.Z., Xu M.E., Ge Y.K., and Xiao G.F. Inhibitory effects of saponins from Anemarrhena asphodeloides Bunge on the growth of vascular smooth muscle cells. Biomed. Environ. Sci. 19 3 (2006) 185-191
46. Yasunari K., Kohno M., Kano H., Yokokawa K., Horio T., and Yoshikawa J. Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose. Arterioscler. Thromb. Vasc. Biol. 15 12 (1995) 2207-2212
47. Michalak M., Robert Parker J.M., and Opas M. Ca2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium 32 5-6 (2002) 269-278
48. Mueller C.F., Wassmann K., Berger A., Holz S., Wassmann S., and Nickenig G. Differential phosphorylation of calreticulin affects AT1 receptor mRNA stability in VSMC. Biochem. Biophys. Res. Commun. 370 4 (2008) 669-674
49. Goldman R.D., Gruenbaum Y., Moir R.D., Shumaker D.K., and Spann T.P. Nuclear lamins: building blocks of nuclear architecture. Genes Dev. 16 5 (2002) 533-547
50. Pugh G.E., Coates P.J., Lane E.B., Raymond Y., and Quinlan R.A. Distinct nuclear assembly pathways for lamins A and C lead to their increase during quiescence in Swiss 3T3 cells. J. Cell Sci. 110 19 (1997) 2483-2493
51. Ivorra C., Kubicek M., González J.M., Sanz-González S.M., Alvarez-Barrientos A., O'Connor J.E., Burke B., and Andrés V. A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C. Genes Dev. 20 3 (2006) 307-320
52. Angel P., and Karin M. The role of Jun, Fos, and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072 2-3 (1991) 129-157
53. Lee I., Lee H., Kim J.M., Chae E.H., Kim S.J., and Chang N. Short-term hyperhomocysteinemia-induced oxidative stress activates retinal glial cells and increases vascular endothelial growth factor expression in rat retina. Biosci. Biotechnol. Biochem. 71 5 (2007) 1203-1210
54. Oh S.H., Adler H.J., Raphael Y., and Lomax M.I. WDR1 colocalizes with ADF and actin in the normal and noise-damaged chick cochlea. J. Comp. Neurol. 448 4 (2002) 399-409
55. Suh M.W., Shin D.H., Lee H.S., Park J.Y., Kim C.S., and Oh S.H. WDR1 expression in the normal and noise-damaged chick vestibule. J. Vestib. Res. 17 4 (2007) 163-170
56. Kueh H.Y., Charras G.T., Mitchison T.J., and Brieher W.M. Actin disassembly by cofilin, coronin, and Aip1 occurs in bursts and is inhibited by barbed-end cappers. J. Cell Biol. 182 2 (2008) 341-353
57. Chew C.S., and Brown M.R. Histamine increases phosphorylation of 27 and 40 kDa parietal cell proteins. Am. J. Physio1. 253 6 Pt. 1 (1987) G823-829
58. Grunewald T.G., Kammerer U., Schulze E., Schindler D., Honig A., Zimmer M., and Butt E. Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells. Exp. Cell Res. 312 7 (2006) 974-982
59. Grunewald T.G., Kammerer U., Winkler C., Schindler D., Sickmann A., Honig A., and Butt E. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. Br. J. Cancer, 96 2 (2007) 296-305
60. Sommer S., Hunzinger C., Schillo S., Klemm M., Biefang-Arndt K., Schwall G., Putter S., Hoelzer K., Schroer K., Stegmann W., and Schrattenholz A. Molecular analysis of homocysteic acid-induced neuronal stress. J. Proteome. Res. 3 3 (2004) 572-581